Galit Levin
Impact in
- Pharmaceutical Science top 0.5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Advancements in Transdermal Drug Delivery 8
-
- Antioxidant Activity and Oxidative Stress 4
- Co-authors
- Shoshana Mokady (6 shared papers)Ilan Ziv (10 shared papers)Anat Shirvan (10 shared papers)Ayelet Reshef (10 shared papers)Avi Adam Cohen (10 shared papers)Hagit Grimberg (10 shared papers)Amiram Raz (3 shared papers)Uri Cogan (2 shared papers)
- Journals
- Journal of Controlled Release (2 papers)APOPTOSIS (2 papers)Advanced Healthcare Materials (2 papers)Mechanisms of Ageing and Development (1 paper)Journal of Nuclear Medicine (1 paper)
- Partner nations
- IsraelUnited KingdomUnited States
In The Last Decade
Galit Levin
29 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 434
- Biochemistry 171
- Dermatology 203
- Biotechnology 63
- Molecular Biology 489
Countries citing papers authored by Galit Levin
This map shows the geographic impact of Galit Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galit Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galit Levin more than expected).
Fields of papers citing papers by Galit Levin
This network shows the impact of papers produced by Galit Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galit Levin. The network helps show where Galit Levin may publish in the future.
Co-authors
The 25 scholars most cited alongside Galit Levin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 138 | |
| 2 | 2003 | 114 | |
| 3 | 2005 | 114 | |
| 4 | 1994 | 103 | |
| 5 | 2009 | 98 | |
| 6 | 2006 | 90 | |
| 7 | 2005 | 75 | |
| 8 | 2020 | 74 | |
| 9 | 2002 | 72 | |
| 10 | 2008 | 65 | |
| 11 | 1997 | 64 | |
| 12 | 1990 | 60 | |
| 13 | 2001 | 59 | |
| 14 | 2006 | 50 | |
| 15 | 2009 | 44 | |
| 16 | 2014 | 31 | |
| 17 | 2007 | 31 | |
| 18 | 1992 | 30 | |
| 19 | 2007 | 30 | |
| 20 | 1995 | 26 |
About Galit Levin
Galit Levin is a scholar working on Pharmaceutical Science, Biochemistry, Dermatology, Biotechnology and Insect Science, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (8 papers), Cell death mechanisms and regulation (4 papers), Antioxidant Activity and Oxidative Stress (4 papers), Bee Products Chemical Analysis (3 papers), Metal complexes synthesis and properties (3 papers), Inflammatory mediators and NSAID effects (3 papers), Dermatology and Skin Diseases (3 papers) and Molecular Sensors and Ion Detection (3 papers). The work is most often cited by research in Pharmaceutical Science (434 citations), Biochemistry (171 citations), Dermatology (203 citations), Biotechnology (63 citations) and Molecular Biology (489 citations). Galit Levin has collaborated with scholars based in Israel, United Kingdom and United States. Frequent co-authors include Shoshana Mokady, Ilan Ziv, Anat Shirvan, Ayelet Reshef, Avi Adam Cohen, Hagit Grimberg, Amiram Raz, Uri Cogan, Dvora Kidron and Amnon C. Sintov. Their work appears in journals such as Journal of Controlled Release, APOPTOSIS, Advanced Healthcare Materials, Mechanisms of Ageing and Development and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.